More than 80 clinicians, researchers and academics have signed an open letter expressing grave concerns about NHS England's recent evidence reviews of gender-affirming hormone therapy (GAHT) for transgender young people and the subsequent prescribing policy. In March this year, NHS England launched a public consultation on their revised prescribing policy for GAHT for those under 18. Under this updated policy, gender-affirming hormones are no longer accessible before the age of 18, representing